Accurate detection of fetomaternal hemorrhage is essential to prevent hemolytic disease of the fetus and newborn (HDFN) in ...

Learn more about haptoglobin, including what it is, how it works and why infants with HDFN often have low haptoglobin levels.

A recent study found that an anti-Kell antibody level of eight can be used to reliably identify patients at risk of severe ...

Learn more about rebound hyperbilirubinemia in newborns, including its causes, symptoms and treatment options.

Integrating genetic data with immunological and blood testing can improve detection of HDFN due to ABO incompatibility, a ...

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...

Fenofibrate therapy may significantly lower bilirubin levels in full-term infants with newborn jaundice who have levels below ...